Microchip Technology (MCHP) Financials

Microchip Technology’s latest results show a meaningful rebound in revenue and profitability from the weak period a year ago, but the balance sheet still carries a lot of debt and the current quarter was pressured by refinancing activity and weak operating capital.

In fiscal Q4 2026, Microchip reported $1.31 billion in revenue, up from $1.19 billion in Q3 2026 and above the $970.5 million it posted in the same quarter last year. Gross profit improved to $799.6 million, and operating income climbed to $217.4 million, a strong turnaround versus the operating loss reported in the prior-year Q4 period. Net income attributable to common shareholders was $116.4 million, or $0.22 per share, compared with a loss of $156.8 million in Q4 2025.

The longer trend is also encouraging. Over the last several quarters, revenue has recovered from the low point seen in Q1 2026, when Microchip posted just $1.08 billion in sales and a net loss. Since then, quarterly revenue has generally improved, while earnings have moved back into positive territory. That suggests demand and operating leverage are gradually normalizing, although the pace of recovery has been uneven.

Cash flow remains an important strength. In Q4 2026, Microchip generated $257 million in operating cash flow, which more than covered $52.1 million of capital spending. For the full quarter, free cash flow appears solid despite weaker working-capital dynamics. Management has also continued to return cash to shareholders, with $274.4 million paid in dividends during the quarter.

Still, the capital structure is the biggest issue investors should watch. On the Q3 2026 balance sheet, Microchip had $11.83 billion in total debt, including $5.37 billion of long-term debt and $6.46 billion of short-term debt. Cash and equivalents were only $250.7 million. That means the company remains heavily leveraged relative to cash on hand, even though it has shown an ability to service debt through operating cash flow and refinancing.

Balance sheet trends over the past year are mixed. Total assets were roughly flat to slightly higher, while equity improved from $6.28 billion in Q2 2026 to $6.56 billion in Q3 2026. However, current liabilities rose and debt levels remained elevated, which keeps financial flexibility limited. Inventory also remains significant, suggesting working capital is still absorbing cash.

• Revenue rebounded to $1.31 billion in Q4 2026, up year over year from $970.5 million in Q4 2025.
• Profitability improved sharply, with operating income of $217.4 million versus an operating loss a year earlier.
• Net income turned positive at $116.4 million attributable to common shareholders, or $0.22 per share.
• Operating cash flow remained strong at $257 million in Q4 2026.
• Capital spending stayed manageable at $52.1 million, supporting cash generation.
• Retained earnings increased on the balance sheet, reflecting a better earnings profile over time.
• Dividend payments remain significant, with $274.4 million paid in the quarter, showing shareholder returns continue to be a priority.
• Debt refinancing remains active; Microchip issued $2.93 billion of debt and repaid $2.80 billion in Q4 2026, indicating ongoing balance-sheet management.
• Debt remains very high at about $11.8 billion on the latest reported balance sheet, far above cash on hand.
• Working capital pressure persists, as changes in operating assets and liabilities were a drag on Q4 2026 cash flow.

Bottom line: Microchip Technology is showing clear signs of operational recovery, with better sales, margins, and earnings than a year ago. But investors should not ignore the heavy debt load and the company’s dependence on strong cash flow and refinancing to keep the balance sheet stable. If the revenue rebound continues, the stock’s fundamentals could keep improving; if growth stalls, leverage will remain a major risk.